Literature DB >> 30239004

Cholesterol burden in the liver induces mitochondrial dynamic changes and resistance to apoptosis.

Mayra Domínguez-Pérez1,2,3, Arturo Simoni-Nieves1,2, Patricia Rosales2, Natalia Nuño-Lámbarri4, Mónica Rosas-Lemus5, Verónica Souza1,6, Roxana U Miranda1,6, Leticia Bucio1,6, Salvador Uribe Carvajal5, Jens U Marquardt7, Daekwan Seo8, Luis E Gomez-Quiroz1,6, María Concepción Gutiérrez-Ruiz1,6.   

Abstract

Non-alcoholic fatty liver disease (NAFLD) encompasses a broad spectrum of histopathological changes ranging from non-inflammatory intracellular fat deposition to non-alcoholic steatohepatitis (NASH), which may progress into hepatic fibrosis, cirrhosis, or hepatocellular carcinoma. Recent data suggest that impaired hepatic cholesterol homeostasis and its accumulation are relevant to the pathogenesis of NAFLD/NASH. Despite a vital physiological function of cholesterol, mitochondrial dysfunction is an important consequence of dietary-induced hypercholesterolemia and was, subsequently, linked to many pathophysiological conditions. The aim in the current study was to evaluate the morphological and molecular changes of cholesterol overload in mouse liver and particularly, in mitochondria, induced by a high-cholesterol (HC) diet for one month. Histopathological studies revealed microvesicular hepatic steatosis and significantly elevated levels of liver cholesterol and triglycerides leading to impaired liver synthesis. Further, high levels of oxidative stress could be determined in liver tissue as well as primary hepatocyte culture. Transcriptomic changes induced by the HC diet involved disruption in key pathways related to cell death and oxidative stress as well as upregulation of genes related to glutathione homeostasis. Impaired liver function could be associated with a decrease in mitochondrial membrane potential and ATP content and significant alterations in mitochondrial dynamics. We demonstrate that cholesterol overload in the liver leads to mitochondrial changes which may render damaged hepatocytes proliferative and resistant to cell death whereby perpetuating liver damage.
© 2018 Wiley Periodicals, Inc.

Entities:  

Keywords:  apoptosis; cholesterol; mitochondrial dynamics; oxidative stress

Year:  2018        PMID: 30239004     DOI: 10.1002/jcp.27474

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  17 in total

1.  25-HC promotes hepatocellular carcinoma metastasis through up-regulation of TLR4 dependent FABP4.

Authors:  Saisai Wang; Yuanyuan Yao; Xiao Wang; Gang Zheng; Wei Ouyang; Wenbin Chen
Journal:  Am J Cancer Res       Date:  2019-10-01       Impact factor: 6.166

Review 2.  Understanding the Role of Metabolic Syndrome as a Risk Factor for Hepatocellular Carcinoma.

Authors:  Norberto C Chavez-Tapia; Sofía Murúa-Beltrán Gall; Ana Luisa Ordoñez-Vázquez; Natalia Nuño-Lambarri; Paulina Vidal-Cevallos; Misael Uribe
Journal:  J Hepatocell Carcinoma       Date:  2022-07-05

3.  Dapagliflozin attenuates cholesterol overloading-induced injury in mice hepatocytes with type 2 diabetes mellitus (T2DM) via eliminating oxidative damages.

Authors:  Liu Yang; Dan Liu; Hongqin Yan; Kaixia Chen
Journal:  Cell Cycle       Date:  2022-01-31       Impact factor: 4.534

4.  Cholesterol enrichment in liver mitochondria impairs oxidative phosphorylation and disrupts the assembly of respiratory supercomplexes.

Authors:  Estel Solsona-Vilarrasa; Raquel Fucho; Sandra Torres; Susana Nuñez; Natalia Nuño-Lámbarri; Carlos Enrich; Carmen García-Ruiz; José C Fernández-Checa
Journal:  Redox Biol       Date:  2019-05-09       Impact factor: 11.799

Review 5.  GDF11 Implications in Cancer Biology and Metabolism. Facts and Controversies.

Authors:  Arturo Simoni-Nieves; Monserrat Gerardo-Ramírez; Gibrán Pedraza-Vázquez; Lisette Chávez-Rodríguez; Leticia Bucio; Verónica Souza; Roxana U Miranda-Labra; Luis E Gomez-Quiroz; María Concepción Gutiérrez-Ruiz
Journal:  Front Oncol       Date:  2019-10-15       Impact factor: 6.244

6.  Icosabutate Exerts Beneficial Effects Upon Insulin Sensitivity, Hepatic Inflammation, Lipotoxicity, and Fibrosis in Mice.

Authors:  Anita M van den Hoek; Elsbet J Pieterman; José W van der Hoorn; Marta Iruarrizaga-Lejarreta; Cristina Alonso; Lars Verschuren; Tore Skjæret; Hans M G Princen; David A Fraser
Journal:  Hepatol Commun       Date:  2019-12-24

Review 7.  Relevance of Membrane Contact Sites in Cancer Progression.

Authors:  Aurora Gil-Hernández; Miguel Arroyo-Campuzano; Arturo Simoni-Nieves; Cecilia Zazueta; Luis Enrique Gomez-Quiroz; Alejandro Silva-Palacios
Journal:  Front Cell Dev Biol       Date:  2021-01-12

Review 8.  Nonalcoholic Fatty Liver Disease.

Authors:  Lingling Ding; Yvonne Oligschlaeger; Ronit Shiri-Sverdlov; Tom Houben
Journal:  Handb Exp Pharmacol       Date:  2022

Review 9.  Mitochondrial Dysfunction in the Transition from NASH to HCC.

Authors:  Mélissa Léveillé; Jennifer L Estall
Journal:  Metabolites       Date:  2019-10-16

10.  Genkwadaphnin inhibits growth and invasion in hepatocellular carcinoma by blocking DHCR24-mediated cholesterol biosynthesis and lipid rafts formation.

Authors:  Jie Wu; Ling Guo; Xiaoran Qiu; Yong Ren; Feifei Li; Wei Cui; Shaojiang Song
Journal:  Br J Cancer       Date:  2020-09-22       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.